ViceHaus

Dapoxetine Ibn Al Haytham 60 mg Film-Coated Tablets

€59,90

Label information

At a glance

Active ingredient
Dapoxetine
Listed strength
60 mg
Product form
Standard tablets
Product range
Dapoxetine

Review the product information and consult a qualified healthcare professional before use. Availability and eligibility depend on destination-country requirements.

Dapoxetine Ibn Al Haytham 60 mg Film-Coated Tablets

Dapoxetine Ibn Al Haytham 60 mg Film-Coated Tablets is presented here solely for factual product-label information. Its stated composition and strength must be verified against the original packaging and official manufacturer documentation. Dapoxetine is a short-acting selective serotonin reuptake inhibitor used in certain adult men with a confirmed diagnosis of premature ejaculation. It is not intended for men who have not been clinically diagnosed.

Product details

  • Active ingredient: Dapoxetine
  • Labelled strength: 60 mg
  • Dosage form: Film-coated tablet
  • Reference patient group: Adult men aged 18–64 who meet the diagnostic criteria for premature ejaculation
Strength notice: In the authorized Priligy reference information, 60 mg is not the starting strength. It is considered only after an inadequate response to 30 mg without moderate or severe adverse effects, and adverse effects are more frequent or more severe at 60 mg. Follow the exact product-specific prescription.

Before use

A licensed prescriber should assess the diagnosis, heart and blood-pressure conditions, fainting or orthostatic symptoms, mood and psychiatric history, seizure history, liver and kidney function, bleeding risk, and all medicines, supplements, and recreational substances. The authorized Priligy reference information states that dapoxetine should not be used by patients taking PDE5 inhibitors such as sildenafil or tadalafil because of possible reduced orthostatic tolerance.

Important safety information

Dapoxetine can cause nausea, dizziness, headache, light-headedness, and fainting. Avoid alcohol because it can increase drowsiness, impaired judgement, fainting, and accidental injury. Maintain adequate hydration and avoid driving or hazardous machinery if dizziness, light-headedness, or fainting symptoms occur.

Do not combine dapoxetine with monoamine oxidase inhibitors (MAOIs), thioridazine, other serotonergic medicines—including many SSRIs, SNRIs, tricyclic antidepressants, tramadol, linezolid, lithium, triptans, or St John’s wort—or strong CYP3A4 inhibitors. Required washout periods and interactions must be checked by a doctor or pharmacist. Stop use and seek urgent medical help for fainting, seizure, severe allergic reaction, marked agitation or other possible serotonin-syndrome symptoms, or distressing changes in mood or thoughts.

Storage and quality checks

Keep in the original packaging, out of the sight and reach of children, and protect from heat and moisture. Check that the seal, batch details, and expiry date are intact and legible. Do not use a damaged or visibly altered package.

Regulatory notice

Reference information on this page concerns dapoxetine and the authorized Priligy 60 mg reference product. The exact authorization, dispensing classification, and permitted sale of this branded product depend on its manufacturer documentation and the destination country. Local prescription and pharmacy rules must be followed.

This information does not replace the supplied patient leaflet or advice from a doctor or pharmacist.

Medical reference: HPRA — Priligy 60 mg (dapoxetine)